fbpx

Day: January 17, 2020

Low-battery warning fight

Microsoft’s carbon dating, Google in $1tn club, Logitech’s split keyboard

Don’t tell anyone, but my iPhone charger is hidden under some newspapers on my desk so that it’s less likely to go walkies when I’m not there.

I’ve always taken precautions, with people very eager to “borrow” this vital energy supply, and in future, I may have to bolt my chargers to the desk. The European Union just doubled the chances of me losing them this week when it revived the idea of universal chargers that would fit Apple, Samsung and any other smartphones.

Apart from the extra jeopardy I will face personally, the tech industry’s own selfish interests are in focus here. “The EU-enforced common charger is the enemy of progress” was the headline of a release from the corporate-backed Consumer Choice Center, which said any such move would undermine innovation and restrict competition. It echoed the argument when this last came up from Apple, which is the king of proprietary technologies and whose Lightning connectors are still cursed by anyone wanting to plug in a headphone jack.

I don’t buy their concerns. Where would we be without common USB and HDMI standards, and WiFi and Bluetooth, all with dongle-less backwards compatibility? I would happily trade a little innovation and commercial advantage for those invaluable conformities. 

Of course, legislators are always behind the tech curve and the common charger debate would become moot if we all bought wireless charging mats that removed the need for hard connections completely. Then again, some companies are not being as innovative in taking us to that bright new future as they think they are. Apple announced its AirPower wireless charging mats in 2017, but had to cancel the product less than two years later after struggling to make one that worked properly.

The Internet of (Five) Things

1. Microsoft’s carbon dating The software shop has gone further than other tech giants in committing to become “carbon negative” by 2030 and offset all carbon emissions made since it was founded. The $1.2tn company also announced a $1bn innovation fund to tackle the climate crisis.

2. There’s another trillion-dollar tech titan Alphabet on Thursday became the fourth Big Tech company to reach a market capitalisation of $1tn. Apple was the first public company to achieve the milestone, in August 2018, and is now more than a third of the way to a second trillion. It was followed by Amazon, which has since fallen back below the 13-digit threshold, and then Microsoft. Meanwhile, Tesla’s soaring share price is giving short sellers the heebie jeebies.

3. Peacock proud of its free streaming strategy The last major streaming debut is also the cheapest. Comcast unveiled its NBCUniversal Peacock streaming service on Thursday and said it would be free for its existing cable customers when it launches fully in July. There will be live sports and news, a large catalogue of older sitcoms, and the service will primarily rely on advertising rather than the subscriptions favoured by rivals. “We like the idea of zigging when others zag,” said NBCUniversal chairman Steve Burke.

4. WhatsApp won’t rely on ads Facebook is dropping plans to show ads on its WhatsApp messaging service, according to a report by the Wall Street Journal. WhatsApp disbanded the team working on integrating ads on to the platform recently and even the code they had created was deleted from the app.

5. Ad industry faces wrath of regulator The UK’s data protection regulator is braced to do battle with the country’s £13bn online advertising industry, saying it will start investigating individual companies that are in breach of European data protection law and enforcing it against them. The Information Commissioner’s Office said the ad industry had responded insufficiently to a six-month grace period to get its house in order.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at 
consumerchoicecenter.org

Democratic Debates: Healthcare in the US is twice as expensive as in Europe – But is this really due to high drug prices?

Watching the #DemDebate in Iowa was an interesting lesson on how something becomes true if enough politicians repeat the same twisted fact over and over again. 

Once all candidates had agreed that Iran having a nuclear bomb would be a problem, the debate shifted towards healthcare reform and the fact that the U.S. is the world leader in healthcare spending as a share of GDP (whooping 17.7% of GDP compared to a typical 8-12% when looking at countries such as the UK, France, Canada, Switzerland, or Germany).

Hedge-Fund-Manager-turned politician Tom Steyer opened by saying that the US spends twice as much per person on healthcare than any other developed nation and that’s why we need a stronger role of the government in healthcare. Steyer forgets to mention that the United States is already the global leader in government healthcare spending:

According to the World Health Organization at least 49% of all healthcare expenditure in the United States is paid by the government (state and federal). That gets you close to 9% of the US GDP and is more than public and private health spending in the United Kingdom combined. 

This should make all of us skeptical and get us to question whether a bigger role of government in healthcare spending would actually bring costs down.

Vermont Sen. Bernie Sanders talked about “greed and corruption of pharmaceutical companies“ and lambasted them as the main reason for high health expenditures in the United States. And while it is true that the US is the largest market for drug sales, they account (including retail and inpatient use) for merely 14% of total health expenditures.

Simple math shows us that even if Bernie Sanders becomes POTUS and brings all drug prices down to $0.00, the US’ healthcare spending would still equal 15% of its GDP, and still it a world leader in healthcare spending. All of this while effectively killing any new medical innovations in the country.

These 2-2.5 percentage points in savings could (according to PWC) also be realized by cutting through red tape and the billing madness of the US health system(s). An unknown but significant amount of efficiency gains could be realized by opening up insurance markets nationwide and giving patients in every state more choice when it comes to their insurer.

High salaries for medical professionals (doctors and nurses) are definitely the elephant in the room that political campaigners don’t touch. Even purchase power adjusted medical professionals make easily twice as much as in other (very) developed countries. By opening up the US medical labor market to more immigration, mutual recognition of medical degrees and training, the US could counter ever-rising salaries for professionals. More competition among medical and nursing schools could also tackle student debt of medical professionals.

While merely 0.3 percentage points could be directly saved by reforming medical malpractice laws, a much bigger amount could be saved by doctors reducing their fear of lawsuits. So-called defensive medicine is the behavior of doctors that are worried about getting sued by patients. Some studies estimate that over-prescribing and over-treatments can make up a quarter of total health costs in the United States. While I think that that number is too high, even if it’s just 5% of total health expenditure, we would be able to shave off another percentage point getting us closer to the Switzerlands of the world.

In short: The Democratic candidates don’t have to worry: The US is already the global leader in government health spending per citizen. If they really want to bring total spending down, they should advocate for legal (liability) reform, opening up the medical and nursing job markets to more immigration, and more choice and competition in the insurance market. Nationalizing all pharmaceutical companies and handing out drugs for free won’t do the trick.

Scroll to top
en_USEN